Advertisement
Advertisement
U.S. markets close in 5 hours 42 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.63-0.04 (-0.26%)
As of 10:11AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close15.67
Open15.67
Bid15.72 x 800
Ask15.80 x 1400
Day's Range15.48 - 15.80
52 Week Range13.85 - 26.31
Volume21,263
Avg. Volume204,515
Market Cap476.962M
Beta (5Y Monthly)2.02
PE Ratio (TTM)N/A
EPS (TTM)-5.49
Earnings DateNov 10, 2021 - Nov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MIRM

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Mirum Pharmaceuticals, Inc.
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    22 hours agoMorningstar
View more
Advertisement
Advertisement